Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$5.50
-0.11-1.96%
After Hours: 7:42 PM EDT
Comments
Loading...
Acrivon Therapeutics Stock Price, Quotes and Forecasts
ACRVNASDAQ
Acrivon Therapeutics (ACRV) Forecast
NewsEarningsAcrivon Therapeutics (ACRV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Acrivon Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ACRV | Benzinga
Explore Acrivon Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACRV.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Acrivon Therapeutics (ACRV) stock?
You can purchase shares of Acrivon Therapeutics (NASDAQ:ACRV) through any online brokerage.
Who are Acrivon Therapeutics (ACRV) competitors?
Other companies in Acrivon Therapeutics’s space includes: Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Tango Therapeutics (NASDAQ:TNGX) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for Acrivon Therapeutics (ACRV) stock?
Acrivon Therapeutics has a consensus price target of $22.67.
What is the current price for Acrivon Therapeutics (ACRV)?
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $5.435 last updated March 25, 2025 at 3:37 PM EDT.
Does Acrivon Therapeutics (ACRV) pay a dividend?
There are no upcoming dividends for Acrivon Therapeutics.
When is Acrivon Therapeutics (NASDAQ:ACRV) reporting earnings?
Acrivon Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Acrivon Therapeutics (ACRV) going to split?
There is no upcoming split for Acrivon Therapeutics.
What sector and industry does Acrivon Therapeutics (ACRV) operate in?
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.